LONDON, Feb. 12, 2026 /PRNewswire/ -- Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, announced today that the US Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results